OXFORD, UK – 8 January 2025 – PrecisionLife, a leading precision medicine company focused on complex chronic diseases, announces the appointment of Bill Keating as Chief Commercial Officer, Diagnostics and Healthcare to lead the commercialization of precision medicine applications from its range of innovative new Mechanostic® tests in complex chronic diseases.
iBoxit, KNEE3D and PfBIO have been named winners at a competition showcasing innovative business ideas at Norwich Research Park.
In collaboration with the University of East Anglia (UEA) and The Royal Society, the Innovation Hothouse competition saw eight finalists pitch their innovative ideas to a panel of expert judges.
All were either spin-out or start-up companies founded by researchers, scientists, entrepreneurs or students based on the park campus.
This webinar will feature an academic case study on NaV1.9 as a drug target by Professor David Bulmer (University of Cambridge). The webinar will also include a presentation by Metrion CSO, Dr. Eddy Stevens with an overview of Metrion’s newly developed NaV1.9 screening assays.
A recent study published in the Journal of Pharmaceutical Sciences (https://doi.org/10.1016/j.xphs.2024.10.013) analysed the complexities of three-dimensional crystal packing arrangements of small-molecule drug candidates, focusing on the CCDC Solid Form Health Check to assess the risk of thermodynamically stable solid forms during drug development.
Infex is developing new therapies to meet the rising burden of critical priority infectious disease. Based at Alderley Park in the North West of England, we have a pipeline of drugs in preclinical and clinical development to treat patients suffering from life-threatening infections.
As part of the continued development of the company we are now looking to appoint an enthusiastic Finance Manager to work alongside the CFO and Finance Administrator to provide accurate and up to date financial reporting to the Board and Science Team.
Boyds is delighted to announce the appointment of Matt O’Connor who joins the company as Senior Manager, Regulatory Affairs.
Matt joins Boyds following more than five years at DLRC, where he gained broad experience across the regulatory lifecycle, supporting regulatory procedures in varied therapeutic areas. He is also a member of The Organisation for Professionals in Regulatory Affairs (TOPRA).
Seasoned executive joins PrecisionLife to drive commercial strategy for new first-in-class precision medicine tests to predict and prevent complex, chronic diseases
Applications are invited for an Alliance and Impact Manager to join the Business Development department at Quadram Institute Bioscience (QIB), based in Norwich, UK.
Background:
Location: Nottingham, UK
Read One Nucleus' eNews January issue here
With Tony Jones, One Nucleus' CEO, guiding you on your journey to success in 2025, by signposting you to:
✅ Will Your 2025 Get Off to a Flying Start?
✅ Money: Investment, Partnering & Business Development
✅ People
✅ Technology
✅ Reflections on Genesis 2024
✅ One Nucleus Annual Awards